Total Payments
$9,290
2022 Payments
$34.08
Companies
18
Transactions
76
Medicare Patients
531
Medicare Billing
$49,027
Payment Breakdown by Category
Other$4,825 (51.9%)
Food & Beverage$3,075 (33.1%)
Consulting$1,375 (14.8%)
Education$15.00 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,800 | 3 | 51.7% |
| Food and Beverage | $3,075 | 70 | 33.1% |
| Consulting Fee | $1,375 | 1 | 14.8% |
| Honoraria | $25.00 | 1 | 0.3% |
| Education | $15.00 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Grifols USA, LLC | $4,824 | 4 | $0 (2021) |
| BioCryst Pharmaceuticals, Inc. | $1,375 | 1 | $0 (2020) |
| GlaxoSmithKline, LLC. | $1,232 | 15 | $0 (2022) |
| Shire North American Group Inc | $414.40 | 7 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $353.23 | 7 | $0 (2019) |
| Genentech USA, Inc. | $325.01 | 17 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $172.12 | 8 | $0 (2019) |
| GENZYME CORPORATION | $145.54 | 2 | $0 (2019) |
| PFIZER INC. | $113.92 | 2 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $86.76 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $34.08 | 2 | GlaxoSmithKline, LLC. ($19.08) |
| 2021 | $1,600 | 1 | Grifols USA, LLC ($1,600) |
| 2020 | $4,670 | 8 | Grifols USA, LLC ($3,224) |
| 2019 | $1,064 | 50 | Genentech USA, Inc. ($325.01) |
| 2018 | $1,576 | 11 | GlaxoSmithKline, LLC. ($1,051) |
| 2017 | $346.02 | 4 | Shire North American Group Inc ($223.43) |
All Payment Transactions
76 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/31/2022 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.00 | General |
| Category: Inflammation & Immunology | ||||||
| 06/15/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: RESPIRATORY | ||||||
| 02/24/2021 | Grifols USA, LLC | Xembify (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,600.00 | General |
| Category: Immunology and Neurology | ||||||
| 11/18/2020 | Grifols USA, LLC | Xembify (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: Immunology and Neurology | ||||||
| 07/30/2020 | BioCryst Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,375.00 | General |
| 04/30/2020 | Grifols USA, LLC | Xembify (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Immunology and Neurology | ||||||
| 03/07/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: RESPIRATORY | ||||||
| 03/03/2020 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: ALLERGY | ||||||
| 02/13/2020 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Immunology and Neurology | ||||||
| 02/10/2020 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: IMMUNOLOGY | ||||||
| 02/05/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Respiratory | ||||||
| 12/04/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2019 | Shire North American Group Inc | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $3.54 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2019 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Food and Beverage | In-kind items and services | $53.22 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $7.81 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/08/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $71.84 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/08/2019 | GENZYME CORPORATION | DUPIXENT (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Respiratory | ||||||
| 10/21/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2019 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Immunology | ||||||
| 10/07/2019 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Immunology | ||||||
| 09/20/2019 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Immunology | ||||||
| 09/10/2019 | CSL Behring | Haegarda (Biological) | Honoraria | Cash or cash equivalent | $25.00 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 69 | 73 | $22,715 | $4,534 |
| 2022 | 5 | 213 | 361 | $32,839 | $22,621 |
| 2021 | 5 | 167 | 260 | $24,529 | $17,092 |
| 2020 | 3 | 82 | 87 | $26,117 | $4,780 |
Total Patients
531
Total Services
781
Medicare Billing
$49,027
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 17 | 17 | $6,715 | $1,184 | 17.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 18 | 19 | $4,845 | $1,053 | 21.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 13 | $3,495 | $811.61 | 23.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $4,345 | $765.93 | 17.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 13 | $3,315 | $720.20 | 21.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 76 | 150 | $12,334 | $8,408 | 68.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 44 | 101 | $11,672 | $8,058 | 69.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 47 | 48 | $4,041 | $2,727 | 67.5% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 29 | 45 | $3,476 | $2,465 | 70.9% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 17 | 17 | $1,316 | $962.48 | 73.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 74 | 141 | $11,551 | $8,090 | 70.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 39 | 57 | $6,714 | $4,727 | 70.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 13 | 13 | $2,852 | $2,011 | 70.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 28 | 29 | $2,499 | $1,647 | 65.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 13 | 20 | $912.12 | $616.40 | 67.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 34 | 37 | $13,579 | $2,422 | 17.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 36 | 38 | $9,538 | $1,655 | 17.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 12 | 12 | $3,000 | $702.96 | 23.4% |
About Dr. Mario Rodenas, MD
Dr. Mario Rodenas, MD is a Allergy & Immunology healthcare provider based in North Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1871709063.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mario Rodenas, MD has received a total of $9,290 in payments from pharmaceutical and medical device companies, with $34.08 received in 2022. These payments were reported across 76 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($4,800).
As a Medicare-enrolled provider, Rodenas has provided services to 531 Medicare beneficiaries, totaling 781 services with total Medicare billing of $49,027. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Other Specialties Internal Medicine, Internal Medicine
- Location North Haven, CT
- Active Since 05/15/2007
- Last Updated 02/21/2023
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1871709063
Products in Payments
- Xembify (Biological) $4,824
- Xolair (Biological) $351.04
- XOLAIR (Biological) $253.49
- CINRYZE (Drug) $213.72
- NUCALA (Biological) $179.39
- DUPIXENT (Biological) $172.12
- CUVITRU (Biological) $143.77
- ATOPIC DERMATITIS - DISEASE (Drug) $122.59
- COSENTYX (Biological) $99.74
- EUCRISA (Drug) $98.92
- FASENRA (Drug) $86.76
- Xhance (Drug) $71.84
- CUTAQUIG (Biological) $53.22
- DUPIXENT (Drug) $39.49
- AUVI-Q (Drug) $29.20
- Haegarda (Biological) $25.00
- TRELEGY ELLIPTA (Drug) $19.08
- CIBINQO (Drug) $15.00
- Grastek (Drug) $12.84
- TAKHZYRO (Biological) $9.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.